Stockreport

Arcellx to Present New Data for Its iMMagine-1 Study and Continues Scientific Momentum with Multiple Presentations at the 67th ASH Annual Meeting and Exposition

Arcellx, Inc.  (ACLX) 
PDF -- A more recent data cut will be shared during an oral presentation for the iMMagine-1 study ---- To date, no delayed neurotoxicities, including no Parkinsonism, no cra [Read more]